James E. Hosch
Direktor/Vorstandsmitglied bei Arrogene, Inc.
Aktive Positionen von James E. Hosch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | 13.05.2016 | - |
Karriereverlauf von James E. Hosch
Ehemalige bekannte Positionen von James E. Hosch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
WestPark Capital, Inc.
 WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Portfolio Manager-Aktien | 30.03.2010 | - |
Ausbildung von James E. Hosch
| Texas A&M University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Portfolio Manager-Equities | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
WestPark Capital, Inc.
WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Finance |
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Börse
- Insiders
- James E. Hosch
- Erfahrung
